Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pulmonary/Respiratory Diseases
Disease Category: Cystic Fibrosis
Trial Information
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-770 in Subjects with Cystic Fibrosis and the G551D Mutation
People with Cystic Fibrosis are asked to participate in a research study being conducted by Long Island Jewish Medical Center.
You may be eligible to participate in this study if you:
- Male or female aged 12 years or older
- Have confirmed diagnosis of cystic fibrosis
- Are able to understand and comply with protocol requirements, restrictions, and instructions and likely to complete the study as planned, as judged by the investigator
You may not participate in this study if you have:
- History of any illness or condition that, in the opinion of the investigator might confound the results of the study or pose an additional risk in administering study drug to the subject
- Have a history of solid organ or hematological transplantation
- Or, if you are pregnant, breastfeeding, or intend to become pregnant during the study
Li Chen Wann, Study Coordinator
Biomedical Research Alliance of New York
Long Island Jewish Medical Center
410 Lakeville Road, Suite 107
New Hyde Park, NY 11040
Phone: 516-465-5419
Fax: 516-465-5454
EMail: Lcwann@nshs.edu
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
